Multiplex Leukemia Cytogenetics & PCR Panel (28 Translocations, 80 Breakpoints: CML, AML, ALL) in UAE | 2,800 AED | 2026 DHA Guidelines

تحليل لوحة اللوكيميا المتعددة الإرسال الوراثي الخلوي والجزيئي (28 انتقالاً و80 نقطة كسر: سرطان الدم النخاعي المزمن، النخاعي الحاد، الليمفاوي الحاد) في الإمارات | 2800 درهم | 2026 إرشادات هيئة الصحة بدبي

Executive Summary | ملخص تنفيذي

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (peripheral blood).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation with our specialist team.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO. خدمات منزلية فاخرة: جمع العينات في المنزل بتقنية سلسلة التبريد المعتمدة ISO. التوجيه السريري: استشارة هاتفية بعد الفحص. التأمين: التحقق المباشر من الفواتير عبر واتساب +971 54 548 8731.

Overview

This multiplex cytogenetics and PCR panel simultaneously screens 28 key chromosomal translocations and 80 breakpoints associated with chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) — providing a comprehensive genomic blueprint for diagnosis, risk stratification, and minimal residual disease monitoring. تقوم هذه اللوحة المتقدمة بتحليل 28 انتقالاً كروموسومياً و80 نقطة كسر مرتبطة بسرطانات الدم بدقة عالية.

Feature	Our Test (Multiplex PCR + Cytogenetics)	Closest Alternative (Karyotyping/FISH only)
Precision	>99.9% detection of all 80 breakpoints	~85% – limited to large structural changes
Methodology	Multiplex RT-PCR with LC‑MS/MS cross‑validation	Conventional karyotyping or single‑probe FISH
Turnaround	5–7 working days	14–21 days

Physician Insight & Safety Protocol

Dr. Prabhakar Reddy (DHA License: 61713011) explains: “This panel provides unprecedented molecular clarity for leukemia classification. As a clinician, I still interpret every result within the full clinical picture — never in isolation. Your comfort and safety during sample collection are our top priorities.”

⚠️ Do not discontinue any prescribed medication without consulting your doctor. This test is not a substitute for ongoing medical care.

Exclusion Criteria & Emergency Red Flags

Exclusion for bone marrow aspiration: active skin infection at the puncture site, severe coagulopathy (INR >1.5, platelets <50x10⁹/L), systemic sepsis.

For peripheral blood home collection: acute febrile illness (>38.5°C), inability to provide informed consent.

Pre‑test Info: A valid doctor’s prescription is required, except for surgery clearance, pregnancy‑related monitoring, or pre‑travel screening as per UAE regulations. Sample must be transported immediately (cold chain).

ER Red Flags: If you experience sudden severe bone pain, chest pain, uncontrolled bleeding, or high fever after sample collection, proceed directly to the nearest emergency department.

Patient FAQ & Clinical Guidance

1. What does this test detect and why is it critical for leukemia care?

This advanced molecular panel simultaneously identifies 28 chromosomal translocations and 80 breakpoints, enabling precise leukemia subtyping, risk stratification, and minimal residual disease tracking in a single assay.

يكشف هذا الاختبار عن 28 انتقالاً كروموسومياً و80 نقطة كسر مرتبطة بأنواع سرطان الدم بدقة عالية، مما يساعد الأطباء على تحديد النوع الفرعي وخطة العلاج.

2. How are samples collected and is home service available?

Our ISO‑certified VIP mobile phlebotomy team collects peripheral blood in a temperature‑controlled kit between 8 AM and 11 PM; bone marrow aspirations are performed only in our licensed clinical setting by a specialist.

توفر خدمة السحب المنزلي لجمع عينة الدم المحيطي بواسطة فريق طبي معتمد من الساعة 8 صباحاً حتى 11 مساءً؛ أما عينة نخاع العظم فتؤخذ داخل المنشأة الطبية المرخصة.

3. Will my health insurance cover this test and how is billing handled?

We perform direct insurance verification via WhatsApp before your appointment; most major UAE insurers cover medically necessary leukemia genomic profiling when accompanied by a physician’s request.

نتحقق من تغطية التأمين مباشرة عبر واتساب قبل الموعد؛ تغطي معظم شركات التأمين في الإمارات هذا الفحص الجيني عند تقديم وصفة طبية.

UAE Regulatory Compliance: Operated under Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors) and UAE PDPL (Federal Law No. 45 of 2021). Your data is processed solely within UAE sovereign cloud servers.

Accredited Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All methods are aligned with 2026 DHA/MOHAP standards.

Why This Matters: Recommended by hematologists‑oncologists, clinical geneticists, and histopathologists for patients with suspected or known myeloid/lymphoid malignancies.

دعم ثنائي اللغة متاح